MedPath

New Orleans Pulmonary Hypertension Biobank

Recruiting
Conditions
Systemic Sclerosis
Pulmonary Hypertension
Healthy
Heart Failure With Normal Ejection Fraction
Mixed Connective Tissue Disease
Interventions
Other: No intervention. Biospecimen collection only
Registration Number
NCT03269630
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Brief Summary

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria
  • Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Undergoing outpatient right heart catheterization
Exclusion Criteria
  • Age<18
  • Pregnant
  • Unable to understand English
  • Currently incarcerated
  • Unwilling or unable to sign informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Outpatient right heart catheterization patientsNo intervention. Biospecimen collection only-Outpatients undergoing right heart catheterization for any indication
Clinic patients (Comprehensive Pulmonary Hypertension Center)No intervention. Biospecimen collection only* Pulmonary hypertension patients (WHO group 1-5) * Systemic sclerosis patients without pulmonary hypertension * Mixed connective tissue disease patients without pulmonary hypertension
Healthy controlsNo intervention. Biospecimen collection only* Age\>18 * Not actively smoking * No chronic medical conditions
Primary Outcome Measures
NameTimeMethod
Collection of biospecimens10 years

Biospecimen collection only

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Medical Center-New Orleans

🇺🇸

New Orleans, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath